Published April 1, 2023
According to new research from the Cleveland Clinic in Ohio, about 41% of individuals with long COVID report moderate to severe sleep issues. Based on data from 962 long COVID patients, risk factors for lingering sleep disturbances were found to include race, hospitalization for COVID-19, and greater severity of anxiety and fatigue.
“Sleep difficulties and fatigue are widely reported by people with long COVID, but little is known about the severity and factors associated with these symptoms,” said lead author Cinthya Pena Orbea, MD, assistant professor of medicine at Cleveland Clinic’s Sleep Disorders Center.
Other findings include:
The most up-to-date data from UBCoV shows similar results to Cleveland Clinic's new research. Based on 663 long COVID patients, our data shows:
For many long COVID patients, the care needed to manage their chronic illness has left them in medical debt. It’s unclear how many patients are being denied coverage, but recent findings estimate that individual medical costs of long COVID come to roughly $9,000 a year.
Part of the problem, according to experts, is the ambiguity of long COVID and its symptoms. This leaves insurance companies denying claims for care because they don’t deem it as a “medical necessity.”
Patients can improve their chances of insurance approving their claims by having a plan before entering the doctor’s office, using the following steps:
If you are interested, call Guttuso at (716) 829-5454 for more information.
New findings suggest that the presence of multiple nutritional deficiencies (MND) can lead to severe COVID-19 infections, especially for those with zinc and selenium deficiencies. It’s estimated that 5.7% of Americans lack two or more essential nutrients with stress being a leading cause of many deficiencies. People at higher risk of infection due to multiple nutritional deficiencies and high stress levels are also more likely to have long-term COVID. It’s important to note that these findings show that deficiencies in other essential nutrients, aside from zinc and selenium, can also lead to higher risks for individuals.
Sue Sisley, MD, who researches psilocybin, a psychedelic, at Scottsdale Research Institute in Phoenix became interested in using psychedelics as long COVID remedies after patients told her they were trying them on their own and seeing improvements. She believes that psilocybin may help long COVID patients by stimulating new neuronal connections and tissue growth in the brain and reducing inflammation in the body. She is seeking research funding to support her hypotheses. The existing research — not in humans — shows that psychedelic drugs have anti-inflammatory effects in rodents. Despite positive reports about long COVID and psychedelics, they have not yet proven effective; however, this article in Time discusses the potential of these substances as a treatment for long COVID, and other conditions.
If you had COVID-19 and would like to participate, enter the registry and begin filling out the questionnaire.
If you have already participated, feel free to share with others who may be interested.
Contact us: (716) 382 - 1808 / firstname.lastname@example.org